• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

接受血液透析患者的肌肉减少症与炎症

Sarcopenia and inflammation in patients undergoing hemodialysis.

作者信息

Hortegal Elane Viana Furtado, Alves Janete Janete Daniel Alencar, Santos Elton Jonh Freitas, Nunes Liliane Carvalho Rodrigues, Galvão Jacqueline Carvalho, Nunes Rafael Ferreira, Lula Dejane de Almeida, Carvalho Suena Cristina Rodrigues de, França Ana Karina Teixeira da Cunha, Santos Elisângela Milhomem Dos, Santos Alcione Miranda Dos

机构信息

Department of Physiological Sciences. Federal University of Maranhão.

Postgraduate Program in Health Science. Universidade Federal do Maranhão.

出版信息

Nutr Hosp. 2020 Aug 27;37(4):855-862. doi: 10.20960/nh.03068.

DOI:10.20960/nh.03068
PMID:32762235
Abstract

Introduction: in individuals with chronic kidney disease, sarcopenia is prevalent and is associated with increased morbidity and mortality, and the occurrence of cardiovascular complications. Objective: to verify the relationship between sarcopenia and inflammation in hemodialysis patients. Methods: a cross-sectional study with 209 patients in five hemodialysis units. Demographic, socioeconomic, body composition, clinical laboratory, and functional data were collected. Sarcopenia was diagnosed according to the European Working Group on Sarcopenia in Older People (grip strength < 27 kg for men and < 16 kg for women; DEXA muscle mass < 7.0 kg/m² for men and < 5.5 kg/m² for women). Inflammation was assessed by C-reactive protein. Results: mean age was 51.9 ± 15.0 years, with a predominance of males (59.3 %). The prevalence of sarcopenia was 29.1 % and that of inflammation was 50.2 %. A Poisson regression analysis showed that sarcopenia was associated with increased hsCRP values (PR: 1.06; 95 % CI: 1.01-1.10; p-value = 0.005); BMI (PR: 0.74; 95 % CI: 0.65-0.84; p-value < 0.001); age (PR: 1.02; 95 % CI: 1.00-1.03; p < 0.001); male (PR: 5.75; 95 % CI: 3.20-10.34; p-value < 0.001); presence of diabetes mellitus (DM) (PR: 1.87; 95 % CI: 1.27-2.74; p-value < 0.001); % body fat (PR: 1.07; 95 % CI: 1.04-1.09; p-value < 0.001). Conclusion: the prevalence of sarcopenia can be considered high in this study, as well as inflammation. Being inflamed, presence of DM, being male, increasing age, and % body fat were risk factors for sarcopenia. On the other hand, increased BMI had a protective role.

摘要

引言

在慢性肾脏病患者中,肌肉减少症很常见,且与发病率和死亡率增加以及心血管并发症的发生有关。目的:验证血液透析患者中肌肉减少症与炎症之间的关系。方法:对五个血液透析单位的209名患者进行横断面研究。收集人口统计学、社会经济、身体成分、临床实验室和功能数据。根据欧洲老年人肌肉减少症工作组的标准诊断肌肉减少症(男性握力<27千克,女性握力<16千克;双能X线吸收法测定的肌肉量男性<7.0千克/平方米,女性<5.5千克/平方米)。通过C反应蛋白评估炎症。结果:平均年龄为51.9±15.0岁,男性占多数(59.3%)。肌肉减少症的患病率为29.1%,炎症的患病率为50.2%。泊松回归分析显示,肌肉减少症与高敏C反应蛋白值升高相关(PR:1.06;95%置信区间:1.01-1.10;p值=0.005);体重指数(PR:0.74;95%置信区间:0.65-0.84;p值<0.001);年龄(PR:1.02;95%置信区间:1.00-1.03;p<0.001);男性(PR:5.75;95%置信区间:3.20-10.34;p值<0.001);糖尿病(DM)的存在(PR:1.87;95%置信区间:1.27-2.74;p值<0.001);体脂百分比(PR:1.07;95%置信区间:1.04-1.09;p值<0.001)。结论:在本研究中,肌肉减少症以及炎症的患病率都可被认为较高。炎症、糖尿病的存在、男性、年龄增长和体脂百分比是肌肉减少症的危险因素。另一方面,体重指数增加具有保护作用。

相似文献

1
Sarcopenia and inflammation in patients undergoing hemodialysis.接受血液透析患者的肌肉减少症与炎症
Nutr Hosp. 2020 Aug 27;37(4):855-862. doi: 10.20960/nh.03068.
2
Sarcopenia in patients with chronic kidney disease not yet on dialysis: Analysis of the prevalence and associated factors.尚未接受透析的慢性肾脏病患者的肌肉减少症:患病率及相关因素分析
PLoS One. 2017 Apr 27;12(4):e0176230. doi: 10.1371/journal.pone.0176230. eCollection 2017.
3
Differences in the prevalence of sarcopenia in peritoneal dialysis patients using hand grip strength and appendicular lean mass: depends upon guideline definitions.使用握力和四肢瘦体重评估腹膜透析患者中肌少症的患病率差异:取决于指南定义。
Eur J Clin Nutr. 2018 Jul;72(7):993-999. doi: 10.1038/s41430-018-0238-3. Epub 2018 Jun 19.
4
The diagnosis of sarcopenia is mainly driven by muscle mass in hemodialysis patients.肌肉减少症的诊断主要由血液透析患者的肌肉量驱动。
Clin Nutr. 2017 Dec;36(6):1654-1660. doi: 10.1016/j.clnu.2016.10.016. Epub 2016 Oct 22.
5
Differences in Prevalence of Muscle Weakness (Sarcopenia) in Haemodialysis Patients Determined by Hand Grip Strength Due to Variation in Guideline Definitions of Sarcopenia.由于肌少症定义指南的差异,通过手握力测定的血液透析患者肌肉无力(肌少症)患病率存在差异。
Nutr Clin Pract. 2018 Apr;33(2):255-260. doi: 10.1002/ncp.10003. Epub 2018 Jan 26.
6
Impact of diabetes on sarcopenia and mortality in patients undergoing hemodialysis.糖尿病对血液透析患者肌少症和死亡率的影响。
BMC Nephrol. 2019 Mar 28;20(1):105. doi: 10.1186/s12882-019-1271-8.
7
Chronic kidney disease-related sarcopenia as a prognostic indicator in elderly haemodialysis patients.慢性肾脏病相关肌少症作为老年血液透析患者的预后指标。
BMC Nephrol. 2023 May 19;24(1):138. doi: 10.1186/s12882-023-03175-5.
8
Prevalence of Osteosarcopenia and Its Association with Cardiovascular Risk Factors in Iranian Older People: Bushehr Elderly Health (BEH) Program.伊朗老年人中骨肌减少症的流行情况及其与心血管危险因素的关系:布什尔老年健康(BEH)计划。
Calcif Tissue Int. 2020 Apr;106(4):364-370. doi: 10.1007/s00223-019-00646-6. Epub 2019 Dec 17.
9
Sarcopenia, sarcopenic obesity and inflammation: Results from the 1999-2004 National Health and Nutrition Examination Survey.肌肉减少症、肌肉减少性肥胖与炎症:1999 - 2004年美国国家健康与营养检查调查结果
Clin Nutr. 2016 Dec;35(6):1472-1483. doi: 10.1016/j.clnu.2016.03.028. Epub 2016 Apr 7.
10
[Frequency of sarcopenia, cachexia, and associated factors in patients with chronic kidney disease in dialysis treatment].[透析治疗的慢性肾脏病患者中肌肉减少症、恶病质及相关因素的发生率]
Nutr Hosp. 2020 Dec 16;37(6):1157-1165. doi: 10.20960/nh.02954.

引用本文的文献

1
Muscle Quality Assessed by the Phase Angle Can Predict Renal Prognosis in Patients with Chronic Kidney Disease.通过相位角评估的肌肉质量可预测慢性肾脏病患者的肾脏预后。
J Clin Med. 2025 Aug 11;14(16):5664. doi: 10.3390/jcm14165664.
2
Prevalence and Risk Factors of Sarcopenia in People Receiving Dialysis: A Systematic Review and Meta-Analysis.接受透析治疗的人群中肌肉减少症的患病率及危险因素:一项系统评价和荟萃分析。
Semin Dial. 2025 Jul-Aug;38(4):237-249. doi: 10.1111/sdi.70000. Epub 2025 Jul 8.
3
Comprehensive Insights into Sarcopenia in Dialysis Patients: Mechanisms, Assessment, and Therapeutic Approaches.
透析患者肌肉减少症的综合见解:机制、评估和治疗方法
Medicina (Kaunas). 2025 Mar 4;61(3):449. doi: 10.3390/medicina61030449.
4
Sarcopenia is associated with increased major adverse cardiovascular event incidence in maintenance hemodialysis patients: a prospective cohort study and mediation analysis.肌肉减少症与维持性血液透析患者主要不良心血管事件发生率增加相关:一项前瞻性队列研究及中介分析
Front Nutr. 2024 Sep 9;11:1426855. doi: 10.3389/fnut.2024.1426855. eCollection 2024.
5
Neutrophil-to-lymphocyte ratio is associated with sarcopenia risk in overweight maintenance hemodialysis patients.中性粒细胞与淋巴细胞比值与超重维持性血液透析患者发生肌少症的风险相关。
Sci Rep. 2024 Feb 14;14(1):3669. doi: 10.1038/s41598-024-54056-2.
6
Assessment of the components of sarcopenia and quality of life perceived of individuals on hemodialysis.评估血液透析患者的肌肉减少症成分和感知生活质量。
Rev Bras Enferm. 2023 Dec 4;76(6):e20220677. doi: 10.1590/0034-7167-2022-0677. eCollection 2023.
7
Prevalence of Sarcopenia and Its Impact on Cardiovascular Events and Mortality among Dialysis Patients: A Systematic Review and Meta-Analysis.透析患者肌少症的患病率及其对心血管事件和死亡率的影响:系统评价和荟萃分析。
Nutrients. 2022 Sep 30;14(19):4077. doi: 10.3390/nu14194077.
8
Development of a risk prediction nomogram for sarcopenia in hemodialysis patients.开发一种用于血液透析患者肌少症的风险预测列线图。
BMC Nephrol. 2022 Sep 23;23(1):319. doi: 10.1186/s12882-022-02942-0.
9
Dietary Inflammatory Potential Is Associated With Sarcopenia Among Chronic Kidney Disease Population.饮食炎症潜能与慢性肾病患者的肌肉减少症相关。
Front Nutr. 2022 May 11;9:856726. doi: 10.3389/fnut.2022.856726. eCollection 2022.
10
Association between Levocarnitine Treatment and the Change in Knee Extensor Strength in Patients Undergoing Hemodialysis: A Post-Hoc Analysis of the Osaka Dialysis Complication Study (ODCS).左卡尼汀治疗与血液透析患者膝关节伸肌力量变化的关系:大阪透析并发症研究(ODCS)的事后分析。
Nutrients. 2022 Jan 14;14(2):343. doi: 10.3390/nu14020343.